Travere Therapeutics
The Manager, REMS & Clinical Operations oversees Risk Evaluation and Mitigation Strategies programs while supporting Phase 1–3 clinical trial operations. The role ensures regulatory compliance, manages vendor oversight, and drives operational excellence for life-changing therapies in the rare disease space. This position requires translating complex regulatory strategies into execution while collaborating across cross-functional teams.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
21% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Global Quality Auditing Lead - REMS/ GVP & GCP
City of Winnipeg
Senior Director, Regulatory Affairs REMS Program
Cytokinetics
Senior Director, Regulatory Affairs REMS Program
Cytokinetics
Global Quality Auditing Lead - REMS/ GVP & GCP
City of Pierre, South Dakota
Director, REMS Strategy & Operations
Cytokinetics
Clinical Research Associate
Orca Bio